| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.0097 |
0.9 |
| mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.9 |
| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.034 |
0.9 |
| mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.9 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |